Search results
Second Chinese drugmaker seeks approval for Ozempic generic
WHTC 1450 Holland· 5 days agoBy Andrew Silver SHANGHAI (Reuters) - A second Chinese drugmaker has applied for approval to sell a...
Second Chinese drugmaker seeks approval for Ozempic generic
Reuters· 5 days ago, opens new tab said this week its subsidiary was seeking approval to sell the drug to control blood...
Bernie Sanders to grill Novo Nordisk CEO on why weight-loss drugs Ozempic and Wegovy can cost up to...
Business Insider· 3 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA...
Benzinga via AOL· 6 days agoVivani Medical, Inc. (NASDAQ:VANI) announced that the U.S. FDA has cleared its Investigational New...
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA...
Benzinga· 6 days agoVivani Medical, Inc. VANI announced that the U.S. FDA has cleared its Investigational New Drug Application for NPM-119, paving the way for the commencement of the LIBERATE-1 Phase 1 trial. This ...
Second Chinese drugmaker seeks approval for Ozempic generic
AOL· 5 days agoA second Chinese drugmaker has applied for approval to sell a generic version of Novo Nordisk's blockbuster diabetes drug Ozempic in China. Livzon Pharmaceutical Group said this week its subsidiary ...
Why Home-Builder Stocks Can Continue Their Bull Run
Barrons.com· 5 days agoHome inventory is up, but still very low and prices remain high. That means builder profits should remain fat. Plus, exploiting the rush to obesity...